Loading…

In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses...

Full description

Saved in:
Bibliographic Details
Published in:Nuclear medicine and biology 2005-02, Vol.32 (2), p.193-200
Main Authors: Staelens, Ludovicus, Oltenfreiter, Ruth, Dumont, Filip, Waterhouse, Rikki N., Vandenbulcke, Katia, Blanckaert, Peter, Dierckx, Rudi A., Slegers, Guido
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3
cites cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3
container_end_page 200
container_issue 2
container_start_page 193
container_title Nuclear medicine and biology
container_volume 32
creator Staelens, Ludovicus
Oltenfreiter, Ruth
Dumont, Filip
Waterhouse, Rikki N.
Vandenbulcke, Katia
Blanckaert, Peter
Dierckx, Rudi A.
Slegers, Guido
description In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [ 123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [ 123I]-BPB is not a suitable tracer for visualisation of D 3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.
doi_str_mv 10.1016/j.nucmedbio.2004.09.007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67447346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969805104001702</els_id><sourcerecordid>67447346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</originalsourceid><addsrcrecordid>eNqFUcGO0zAQtRCI7S78AviE2IPLOLGThtuqWqDSCpBYTghZjj3ZdZXYIXYqut_BB-PSCo5II814_N6M_R4hLzksOfDqzXbpZzOgbV1YFgBiCc0SoH5EFnxVF6ypuHhMFtBUDVuB5GfkPMYtZKbg8JSccVkXvK7kgvzaeLpzu0Bxp_tZJxc8DR39RnlRbr4zwVywgdGP7LX4EwUbMN2Hn_vxHv2-v2SjG3HSD84zzvK5ndOh26J_0IOz-JZqOoaEPjnd0-juBk0nNDimMNHe3WlvaZfLL5-v17c0ptk6jM_Ik073EZ-f8gX5-u76dv2B3Xx6v1lf3TAjSpkYllAa08oG2kbUumtLAauubEBKWXPIeliBArApCm071MaILABKjlJ3q8qWF-TVce44hR8zxqQGFw32vfYY5qiqWoi6FFUG1kegmUKME3ZqnNygp73ioA6GqK36a4g6GKKgUfkBmfnitGJu8_U_3smBDLg6AjB_dOdwUtE49AatyzolZYP775Lfb1efyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67447346</pqid></control><display><type>article</type><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><source>ScienceDirect Freedom Collection</source><creator>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</creator><creatorcontrib>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</creatorcontrib><description>In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [ 123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [ 123I]-BPB is not a suitable tracer for visualisation of D 3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</description><identifier>ISSN: 0969-8051</identifier><identifier>EISSN: 1872-9614</identifier><identifier>DOI: 10.1016/j.nucmedbio.2004.09.007</identifier><identifier>PMID: 15721765</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>123I ; Animals ; Benzamides - pharmacokinetics ; Brain - diagnostic imaging ; Brain - metabolism ; Dopamine D 3 receptors SPECT ; Feasibility Studies ; Male ; Metabolic Clearance Rate ; Mice ; Organ Specificity ; Piperazines - pharmacokinetics ; Rabbits ; Radiopharmaceuticals - pharmacokinetics ; Receptors, sigma - metabolism ; Sigma receptors ; Species Specificity ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon - methods</subject><ispartof>Nuclear medicine and biology, 2005-02, Vol.32 (2), p.193-200</ispartof><rights>2005 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</citedby><cites>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15721765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Staelens, Ludovicus</creatorcontrib><creatorcontrib>Oltenfreiter, Ruth</creatorcontrib><creatorcontrib>Dumont, Filip</creatorcontrib><creatorcontrib>Waterhouse, Rikki N.</creatorcontrib><creatorcontrib>Vandenbulcke, Katia</creatorcontrib><creatorcontrib>Blanckaert, Peter</creatorcontrib><creatorcontrib>Dierckx, Rudi A.</creatorcontrib><creatorcontrib>Slegers, Guido</creatorcontrib><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><title>Nuclear medicine and biology</title><addtitle>Nucl Med Biol</addtitle><description>In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [ 123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [ 123I]-BPB is not a suitable tracer for visualisation of D 3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</description><subject>123I</subject><subject>Animals</subject><subject>Benzamides - pharmacokinetics</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Dopamine D 3 receptors SPECT</subject><subject>Feasibility Studies</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Mice</subject><subject>Organ Specificity</subject><subject>Piperazines - pharmacokinetics</subject><subject>Rabbits</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Receptors, sigma - metabolism</subject><subject>Sigma receptors</subject><subject>Species Specificity</subject><subject>Tissue Distribution</subject><subject>Tomography, Emission-Computed, Single-Photon - methods</subject><issn>0969-8051</issn><issn>1872-9614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFUcGO0zAQtRCI7S78AviE2IPLOLGThtuqWqDSCpBYTghZjj3ZdZXYIXYqut_BB-PSCo5II814_N6M_R4hLzksOfDqzXbpZzOgbV1YFgBiCc0SoH5EFnxVF6ypuHhMFtBUDVuB5GfkPMYtZKbg8JSccVkXvK7kgvzaeLpzu0Bxp_tZJxc8DR39RnlRbr4zwVywgdGP7LX4EwUbMN2Hn_vxHv2-v2SjG3HSD84zzvK5ndOh26J_0IOz-JZqOoaEPjnd0-juBk0nNDimMNHe3WlvaZfLL5-v17c0ptk6jM_Ik073EZ-f8gX5-u76dv2B3Xx6v1lf3TAjSpkYllAa08oG2kbUumtLAauubEBKWXPIeliBArApCm071MaILABKjlJ3q8qWF-TVce44hR8zxqQGFw32vfYY5qiqWoi6FFUG1kegmUKME3ZqnNygp73ioA6GqK36a4g6GKKgUfkBmfnitGJu8_U_3smBDLg6AjB_dOdwUtE49AatyzolZYP775Lfb1efyQ</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Staelens, Ludovicus</creator><creator>Oltenfreiter, Ruth</creator><creator>Dumont, Filip</creator><creator>Waterhouse, Rikki N.</creator><creator>Vandenbulcke, Katia</creator><creator>Blanckaert, Peter</creator><creator>Dierckx, Rudi A.</creator><creator>Slegers, Guido</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><author>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>123I</topic><topic>Animals</topic><topic>Benzamides - pharmacokinetics</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Dopamine D 3 receptors SPECT</topic><topic>Feasibility Studies</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Mice</topic><topic>Organ Specificity</topic><topic>Piperazines - pharmacokinetics</topic><topic>Rabbits</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Receptors, sigma - metabolism</topic><topic>Sigma receptors</topic><topic>Species Specificity</topic><topic>Tissue Distribution</topic><topic>Tomography, Emission-Computed, Single-Photon - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Staelens, Ludovicus</creatorcontrib><creatorcontrib>Oltenfreiter, Ruth</creatorcontrib><creatorcontrib>Dumont, Filip</creatorcontrib><creatorcontrib>Waterhouse, Rikki N.</creatorcontrib><creatorcontrib>Vandenbulcke, Katia</creatorcontrib><creatorcontrib>Blanckaert, Peter</creatorcontrib><creatorcontrib>Dierckx, Rudi A.</creatorcontrib><creatorcontrib>Slegers, Guido</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine and biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Staelens, Ludovicus</au><au>Oltenfreiter, Ruth</au><au>Dumont, Filip</au><au>Waterhouse, Rikki N.</au><au>Vandenbulcke, Katia</au><au>Blanckaert, Peter</au><au>Dierckx, Rudi A.</au><au>Slegers, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</atitle><jtitle>Nuclear medicine and biology</jtitle><addtitle>Nucl Med Biol</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>32</volume><issue>2</issue><spage>193</spage><epage>200</epage><pages>193-200</pages><issn>0969-8051</issn><eissn>1872-9614</eissn><abstract>In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [ 123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [ 123I]-BPB is not a suitable tracer for visualisation of D 3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15721765</pmid><doi>10.1016/j.nucmedbio.2004.09.007</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0969-8051
ispartof Nuclear medicine and biology, 2005-02, Vol.32 (2), p.193-200
issn 0969-8051
1872-9614
language eng
recordid cdi_proquest_miscellaneous_67447346
source ScienceDirect Freedom Collection
subjects 123I
Animals
Benzamides - pharmacokinetics
Brain - diagnostic imaging
Brain - metabolism
Dopamine D 3 receptors SPECT
Feasibility Studies
Male
Metabolic Clearance Rate
Mice
Organ Specificity
Piperazines - pharmacokinetics
Rabbits
Radiopharmaceuticals - pharmacokinetics
Receptors, sigma - metabolism
Sigma receptors
Species Specificity
Tissue Distribution
Tomography, Emission-Computed, Single-Photon - methods
title In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20evaluation%20of%20%5B%20123I%5D-4-iodo-%20N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide:%20a%20potential%20sigma%20receptor%20ligand%20for%20SPECT%20studies&rft.jtitle=Nuclear%20medicine%20and%20biology&rft.au=Staelens,%20Ludovicus&rft.date=2005-02-01&rft.volume=32&rft.issue=2&rft.spage=193&rft.epage=200&rft.pages=193-200&rft.issn=0969-8051&rft.eissn=1872-9614&rft_id=info:doi/10.1016/j.nucmedbio.2004.09.007&rft_dat=%3Cproquest_cross%3E67447346%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67447346&rft_id=info:pmid/15721765&rfr_iscdi=true